Arrow Clinical Trials LLC – Trademark Portfolio

Entity Type: 16

Arrow Clinical Trials LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include A, A ARROW, ARROW CLINICAL TRIALS, and ADVANCING CLINICAL TRIALS THROUGH ACCURACY, PRECISION AND FOLLOW-THROUGH. The owner is based in Daytona Beach, FL.

1717 N. Clyde Morris Boulevard, Ste 120

Daytona Beach, FL 32117

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Arrow Clinical Trials LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (4 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Arrow Clinical Trials LLC have?

Arrow Clinical Trials LLC has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Arrow Clinical Trials LLC file in?

Arrow Clinical Trials LLC files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Arrow Clinical Trials LLC's most well-known trademarks?

Arrow Clinical Trials LLC's registered trademark portfolio includes well-known marks such as A, A ARROW, ARROW CLINICAL TRIALS, and ADVANCING CLINICAL TRIALS THROUGH ACCURACY, PRECISION AND FOLLOW-THROUGH. These are among 4 currently registered trademarks in the portfolio.

What is Arrow Clinical Trials LLC's trademark registration success rate?

Arrow Clinical Trials LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.